rs199472915
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_000238.4(KCNH2):c.1591C>T(p.Arg531Trp) variant causes a missense change. The variant allele was found at a frequency of 0.000000695 in 1,439,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R531Q) has been classified as Pathogenic.
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.1591C>T | p.Arg531Trp | missense_variant | 7/15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNH2 | ENST00000262186.10 | c.1591C>T | p.Arg531Trp | missense_variant | 7/15 | 1 | NM_000238.4 | ENSP00000262186 | P1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 6.95e-7 AC: 1AN: 1439356Hom.: 0 Cov.: 36 AF XY: 0.00 AC XY: 0AN XY: 712158
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Long QT syndrome 2 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | May 16, 2023 | The KCNH2 c.1591C>T (p.Arg531Trp) missense variant has been identified in four individuals with a phenotype consistent with long QT syndrome (LQTS) and in two individuals with sudden cardiac death (PMID: 19716085; 19804510; 23631430; 28532774; 35091851). Additionally, a different amino acid substitution at the same codon (p.Arg531Gln) has been reported in an individual with LQTS (PMID: 10973849). This variant is not observed in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. The p.Arg531Trp variant is located in the transmembrane segment 4 domain that contains several highly conserved arginine residues that are important for normal Kv11.1 gating. A functional study conducted in human cell lines demonstrated that this variant dramatically altered Kv11.1 gating (PMID: 23546015). Based on the available evidence, the c.1591C>T (p.Arg531Trp) variant is classified as likely pathogenic for long QT syndrome. - |
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Dec 21, 2023 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with Long QT syndrome 2 (MIM#613688). Gain of function is also a known mechanism associated with Short QT syndrome 1 (MIM#609620) (OMIM, PMID: 10753933, 21777565). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0112 - The condition associated with this gene has incomplete penetrance (PMID: 20301308). (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to tryptophan. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0602 - Variant is located in a hotspot region or cluster of pathogenic variants (DECIPHER). (SP) 0704 - Another missense variant comparable to the one identified in this case has limited previous evidence for pathogenicity. An alternative change to a glutamine has been reported in an individual with LQTS (PMID: 10973849). (SP) 0801 -This variant has strong previous evidence of pathogenicity in unrelated individuals. It has been reported in multiple individuals with LQTS (PMID: 19716085, 25967940, 28532774, 32893267, 35911527) and sudden death cases (PMID: 19804510; 35091851). In addition, it has been classified as likely pathogenic/pathogenic in ClinVar, including one VUS classification dated 2020. (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1002 - This variant has moderate functional evidence supporting abnormal protein function. Functional studies have demonstrated altered channel current activation and inactivation (PMID: 16166152, 23546015). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jul 15, 2018 | PM1, PS4_moderate, PM2_supporting, PP3, PP2, PS3_supporting - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 27, 2024 | Identified in multiple unrelated patients with LQTS or sudden cardiac death referred for genetic testing at GeneDx and in the published literature (PMID: 35091851, 19716085, 19804510, 28532774); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22581653, 26105569, 28532774, 19804510, 23631430, 23980196, 25417810, 25967940, 16166152, 23546015, 36525500, 35091851, 19716085, 32893267) - |
Long QT syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 03, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects KCNH2 function (PMID: 23546015). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 67218). This missense change has been observed in individuals with long QT syndrome (PMID: 19716085, 28532774; Invitae). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 531 of the KCNH2 protein (p.Arg531Trp). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Oct 02, 2023 | This missense variant replaces arginine with tryptophan at codon 531 of the KCNH2 protein. This variant is found within the highly conserved transmembrane S4 domain (a.a. 521-541). Rare nontruncating variants in this region have been shown to be significantly overrepresented in individuals with long QT syndrome (PMID: 32893267). Functional studies have shown that this variant causes trafficking deficiency in cardiomyocytes differentiated from human induced pluripotent stem cells (hiPSCs) and impairs potassium channel function in several in vitro cell systems (PMID: 16166152, 23546015, 36525500). This variant has been reported in at least seven unrelated individuals affected with or suspected of having long QT syndrome (PMID: 19716085, 19804510, 23631430, 28532774, 32893267, Clinvar SCV000827271.5) and in another individual affected with sudden cardiac death (PMID: 35091851). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 02, 2020 | Variant summary: KCNH2 c.1591C>T (p.Arg531Trp) results in a non-conservative amino acid change located in the Ion transport domain (S4 domain, Kapplinger_2009) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 238752 control chromosomes (gnomAD and publication data). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1591C>T has been reported in the literature in individuals affected with Long QT syndrome (Kapplinger_2009, Schmitt_2009, Lieve_2013, Ebbrahim_2017). These reports do not provide unequivocal conclusions about association of the variant with Arrhythmia. Functional studies report this variant altered channel current activation and inactivation (Subbiah_2005, McBride_2013). One ClinVar submitter (evaluation after 2014) cites the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at